UMIN ID: UMIN000000643
Registered date:01/10/2013
A open-label study of Entecavir in the patients with acute hepatitis B for preventing chronicity and aggravation
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Acute hepatitis B |
| Date of first enrollment | 2006/10/01 |
| Target sample size | 20 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Entecavir |
Outcome(s)
| Primary Outcome | HBV-DNA |
|---|---|
| Secondary Outcome | transaminase |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Fulminant hepatitis During pregnancy and the possibility of pregnancy Participating in the other clinical trials |
Related Information
| Primary Sponsor | Gunma Liver Study Group |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Gunma Liver Study Group |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Ken Sato |
| Address | 3-39-15 Showa, Maebashi, Gunma, 371-8511, Japan Japan |
| Telephone | 027-220-8127 |
| satoken@showa.gunma-u.ac.jp | |
| Affiliation | Gunma University Graduate School of Medicine Department of Medicine and Molecular Science |
| scientific contact | |
| Name | Ken Sato |
| Address | 3-39-15 Showa, Maebashi, Gunma, 371-8511, Japan Japan |
| Telephone | 027-220-8127 |
| satoken@gunma-u.ac.jp | |
| Affiliation | Gunma University Graduate School of Medicine Department of Medicine and Molecular Science |